Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC
Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC
Not yet recruiting · NCT07152769 · Registry updated 2025-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC | Advanced Intrahepatic Cholangiocarcinoma | Not yet recruiting | Phase 2 | 2025-09-03 | NCT07152769 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 4 |